5-134607048-C-A
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PVS1_StrongPM2PP5_Moderate
The NM_016103.4(SAR1B):c.499G>T(p.Glu167*) variant causes a stop gained change. The variant allele was found at a frequency of 0.000011 in 1,459,654 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.000011 ( 0 hom. )
Consequence
SAR1B
NM_016103.4 stop_gained
NM_016103.4 stop_gained
Scores
5
1
1
Clinical Significance
Conservation
PhyloP100: 6.09
Genes affected
SAR1B (HGNC:10535): (secretion associated Ras related GTPase 1B) The protein encoded by this gene is a small GTPase that acts as a homodimer. The encoded protein is activated by the guanine nucleotide exchange factor PREB and is involved in protein transport from the endoplasmic reticulum to the Golgi. This protein is part of the COPII coat complex. Defects in this gene are a cause of chylomicron retention disease (CMRD), also known as Anderson disease (ANDD). Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Mar 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. There are 4 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 5-134607048-C-A is Pathogenic according to our data. Variant chr5-134607048-C-A is described in ClinVar as [Pathogenic]. Clinvar id is 2734786.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SAR1B | NM_016103.4 | c.499G>T | p.Glu167* | stop_gained | 7/7 | ENST00000402673.7 | NP_057187.1 | |
SAR1B | NM_001033503.3 | c.499G>T | p.Glu167* | stop_gained | 8/8 | NP_001028675.1 | ||
SAR1B | XM_047417257.1 | c.499G>T | p.Glu167* | stop_gained | 7/7 | XP_047273213.1 | ||
SAR1B | XM_047417258.1 | c.295G>T | p.Glu99* | stop_gained | 5/5 | XP_047273214.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SAR1B | ENST00000402673.7 | c.499G>T | p.Glu167* | stop_gained | 7/7 | 1 | NM_016103.4 | ENSP00000385432.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome AF: 0.0000110 AC: 16AN: 1459654Hom.: 0 Cov.: 29 AF XY: 0.0000124 AC XY: 9AN XY: 726292
GnomAD4 exome
AF:
AC:
16
AN:
1459654
Hom.:
Cov.:
29
AF XY:
AC XY:
9
AN XY:
726292
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 25, 2023 | For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the SAR1B protein in which other variant(s) (p.Ser179Arg) have been determined to be pathogenic (PMID: 12692552, 17945526). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. This variant is also known as G19T. This premature translational stop signal has been observed in individual(s) with chylomicron retention disease (PMID: 18786134). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Glu167*) in the SAR1B gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 32 amino acid(s) of the SAR1B protein. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at